The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.
Thromboregulatory physiology is essentially a function of the blood vessel wall. Constitutive endothelial cell activities maintain blood fluidity by down regulating the initiation as well as, the propagation of blood coagulation. The major systems involved include: the Protein C, TFPI, plasmin generating and antithrombin pathways, all of which are focused on the cell membrane. Altered regulation of these endothelial functions forms the basis of the pathophysiologic events associated with the inherited primary hypercoagulable states. Secondary hypercoagulable syndromes occurring in various clinical states with conversion to a vascular thrombogenic phenotype reflect non constitutive activated endothelial cell functions with concomitant down regulation of the constitutive anticoagulant surface activity. So called idiopathic clinical thrombosis in most circumstances represents multi hit events in which specific genetic abnormalities or polymorphisms together with specific acquired alterations in geographically distinct endothelial cell beds culminate in a recognizable coagulation phenotype.
Nachman
R L
RL
Department of Medicine, Weill Medical College of Cornell University, New York Presbyterian Hospital, 525 East 68th Street, BOX 130, New York, NY 10021, USA.
D000818:Animals; D000925:Anticoagulants / Q000097:blood; D001777:Blood Coagulation / Q000502:physiology; D001778:Blood Coagulation Disorders / Q000097:blood / Q000209:etiology* / Q000235:genetics / Q000628:therapy; D001779:Blood Coagulation Factors / Q000235:genetics / Q000502:physiology; D004730:Endothelium, Vascular / Q000503:physiopathology; D005260:Female; D006801:Humans; D051379:Mice; D011247:Pregnancy; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000235:genetics
D000925:Anticoagulants; D001779:Blood Coagulation Factors